Trial intelligence / Profile preview

Phase I Clinical Pharmacology Study of EA4017 in Healthy Adult Male Subjects

jRCT2080224789Phase 1Completed

Sponsor
EA Pharma Co., Ltd.
Start
Jul 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised trial comparing EA4017 with Placebo (2 arms). Primary endpoint: Primary pharmacokinetic endpoints. Started Jul 2019; status: completed.

02

Drugs

EA4017

Beyond the preview

Go deeper on jRCT2080224789.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2080224789.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call